test-1025-5.pdf
Documents & Forms Results
Displaying 1721 - 1730 of 3288 results
Provider
QP88-23 MCG Care Guidelines Transparency Tool Available via Availity Essentials by October 27, 2023
Program effective Date: Oct 25, 2023
Provider
QP82-23 Commercial Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Izervay™, and Veopoz™
Program effective Date: Oct 11, 2023
Provider
QP83-23 Commercial Pharmacy Benefit Exclusion for Budesonide-Formoterol Aerosol Inhaler and Tiotropium Bromide Inhalation Capsule
Program effective Date: Oct 11, 2023
Provider
QP84-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2023
Program effective Date: Oct 11, 2023
Provider
QP85-23 MHCP Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Elrexfio™, Izervay™, Talvey™, and Veopoz™
Program effective Date: Oct 11, 2023
Provider
QP86-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2023
Program effective Date: Oct 11, 2023
Provider
QP87-23 Availity Essentials Updated Claim Entry Forms
Program effective Date: Oct 11, 2023